Fundraising through a Third-Party Allotment of Stock Acquisition Rights
First written in FY2020-Q1. 7 of 13 entries say "Advanced", first in FY2020-Q2. Latest entry: FY2023-Q3.
42 other companies' latest entry also says "Advanced".
- FY2023-Q3AdvancedAnnual report
「During the nine months ended the third quarter of the current consolidated fiscal year, capital stock and capital surplus each increased by ¥154 million in connection with the exercise of stock acquisition rights relating to stock acquisition rights, etc., with exercise price adjustment clauses.」
The Company states that, in connection with the exercise of the Series 2 stock acquisition rights, capital stock and capital surplus each increased by ¥154 million during the nine months ended the third quarter of the current consolidated fiscal year. - FY2023-Q2AdvancedAnnual report
「Proceeds from the issuance of shares through the exercise of stock acquisition rights 308」
During the six months ended the second quarter of the current consolidated fiscal year, the Company recorded ¥308 million in proceeds from the issuance of shares through the exercise of stock acquisition rights, and financing activities remain ongoing. - FY2023-Q1Update to the exercise record for the Series 2 stock acquisition rightsAnnual report
「Number of stock acquisition rights, etc., with exercise price adjustment clauses exercised during the quarter (units) 1,230 Number of shares delivered upon exercise during the quarter (shares) 123,000 Funds raised through exercise during the quarter (¥ millions) 308 Cumulative number of stock acquisition rights, etc., with exercise price adjustment clauses exercised as of the end of the quarter (units) 6,977 Cumulative number of shares delivered in connection with the stock acquisition rights, etc., with exercise price adjustment clauses as of the end of the quarter (shares) 697,700 Cumulative funds raised through the stock acquisition rights, etc., with exercise price adjustment clauses as of the end of the quarter (¥ millions) 1,822」
During the quarter, 1,230 Series 2 stock acquisition rights were exercised, 123,000 shares were delivered and ¥308 million was raised. Cumulatively, 6,977 rights, 697,700 shares and ¥1.822 billion were recorded. - FY2022Acquisition and cancellation of the remaining Series 2 stock acquisition rightsAnnual report
「At a Board of Directors meeting held on 14 July 2022, the Company resolved to acquire and cancel all of its Series 2 stock acquisition rights with exercise price adjustment clauses issued through a third-party allotment. On 28 July 2022, the Company acquired and cancelled all such rights, comprising the remaining 6,023 units. The number of shares delivered in connection with rights exercised between 1 June 2022 and 28 July 2022 was 123,000.」
During the fiscal year, 5,747 Series 2 stock acquisition rights were exercised and ¥1.514 billion was raised. By the filing date, the remaining 6,023 rights had been acquired and cancelled. - FY2022-Q3AdvancedAnnual report
「Number of stock acquisition rights, etc., with exercise price adjustment clauses exercised during the quarter (units) 2,220 Number of shares delivered upon exercise during the quarter (shares) 222,000 Funds raised through exercise during the quarter (¥ thousands) 588,061 Cumulative number of stock acquisition rights, etc., with exercise price adjustment clauses exercised as of the end of the quarter (units) 3,290 Cumulative number of shares delivered in connection with the stock acquisition rights, etc., with exercise price adjustment clauses as of the end of the quarter (shares) 329,000 Cumulative funds raised through the stock acquisition rights, etc., with exercise price adjustment clauses as of the end of the quarter (¥ thousands) 897,033」
During the quarter, 2,220 Series 2 stock acquisition rights were exercised, 222,000 shares were delivered and ¥588.061 million was raised. Cumulatively, 3,290 rights, 329,000 shares and ¥897.033 million were recorded. - FY2022-Q2AdvancedAnnual report
「During the second quarter, stock acquisition rights relating to stock acquisition rights, etc., with exercise price adjustment clauses, were exercised as follows. Number of stock acquisition rights, etc., with exercise price adjustment clauses exercised during the quarter (units) 1,070 Number of shares delivered upon exercise during the quarter (shares) 107,000 Funds raised through exercise during the quarter (¥ thousands) 308,971」
During the quarter, 1,070 Series 2 stock acquisition rights were exercised, 107,000 shares were delivered and ¥308.971 million was raised. - FY2022-Q1Issue of Series 2 stock acquisition rightsAnnual report
「Based on a resolution of the Board of Directors meeting held on 13 September 2021, the Company issued, on 29 September 2021, Series 2 stock acquisition rights with exercise price adjustment clauses through a third-party allotment. The issue comprised 13,000 rights, represented potential shares of 1,300,000 shares and raised ¥4,754,851,000 on a net proceeds basis.」
Separate from the completed Series 1 stock acquisition rights, the Company issued 13,000 Series 2 rights, representing 1,300,000 potential shares, and planned to raise approximately ¥4.754851 billion in net proceeds. - FY2021-Q2AchievedAnnual report
「Cumulative number of stock acquisition rights, etc., with exercise price adjustment clauses exercised as of the end of the quarter (units) 12,000 Cumulative number of shares delivered in connection with the stock acquisition rights, etc., with exercise price adjustment clauses as of the end of the quarter (shares) 1,200,000 Cumulative funds raised through the stock acquisition rights, etc., with exercise price adjustment clauses as of the end of the quarter (¥ thousands) 3,799,084」
A cumulative 12,000 third-party allotment stock acquisition rights were exercised, 1,200,000 shares were delivered and a cumulative ¥3,799.084 million was raised. The figures shown are the final cumulative totals after all issued rights had been exercised. - FY2021-Q1AchievedAnnual report
「Number of stock acquisition rights, etc., with exercise price adjustment clauses exercised during the quarter (units) 4,816 Number of shares delivered upon exercise during the quarter (shares) 481,600 Funds raised through exercise during the quarter (¥ thousands) 1,597,384 Cumulative number of stock acquisition rights, etc., with exercise price adjustment clauses exercised as of the end of the quarter (units) 11,360 Cumulative funds raised through the stock acquisition rights, etc., with exercise price adjustment clauses as of the end of the quarter (¥ thousands) 3,597,924 All rights had been exercised by 24 September 2020.」
During the quarter, 4,816 third-party allotment stock acquisition rights were exercised and ¥1,597.384 million was raised. Cumulatively, 11,360 rights had been exercised and ¥3,597.924 million had been raised, with all rights exercised by 24 September 2020. - FY2020AdvancedAnnual report
「Number of stock acquisition rights, etc., with exercise price adjustment clauses exercised during the period (units) 6,544 Number of shares delivered upon exercise during the period (shares) 654,400 Funds raised through exercise during the period (¥ thousands) 2,000,539」
During the fiscal year, 6,544 Series 1 stock acquisition rights were exercised, 654,400 shares were delivered and ¥2,000.539 million was raised. - FY2020-Q3AdvancedAnnual report
「During the third quarter, share acquisition rights attached to bonds with share acquisition rights and other instruments with provisions for adjustment of the exercise price were exercised as follows. Number of such instruments exercised during the quarter (units) 1,999 Number of shares delivered upon exercise during the quarter (shares) 199,900 Average exercise price, etc., for exercises during the quarter (¥) 3,074.71 Funds raised through exercises during the quarter (¥ thousand) 614,634 Cumulative number of such instruments exercised as of the end of the quarter (units) 3,433 Cumulative number of shares delivered upon exercise of such instruments as of the end of the quarter (shares) 343,300 Cumulative average exercise price, etc., for such instruments as of the end of the quarter (¥) 2,962.84 Cumulative funds raised through exercises of such instruments as of the end of the quarter (¥ thousand) 1,017,143」
During the quarter, 1,999 stock acquisition rights issued through a third-party allotment were exercised, 199,900 shares were delivered and ¥614.634 million was raised. Cumulatively, 3,433 rights had been exercised and total funds raised amounted to ¥1,017.143 million. - FY2020-Q2AdvancedAnnual report
「During the second quarter, share acquisition rights attached to bonds with share acquisition rights and other instruments with provisions for adjustment of the exercise price were exercised as follows. Number of such instruments exercised during the quarter (units) 1,434 Number of shares delivered upon exercise during the quarter (shares) 143,400 Average exercise price, etc., for exercises during the quarter (¥) 2,806.89 Funds raised through exercises during the quarter (¥ thousand) 402,508」
During the quarter, 1,434 share acquisition rights issued through a third-party allotment were exercised, 143,400 shares were delivered and ¥402.508 million was raised. - FY2020-Q1First statedAnnual report
「Based on a resolution of the Board of Directors dated 6 September 2019, the company issued on 24 September 2019, through a third-party allotment, its first series of share acquisition rights with provisions for adjustment of the exercise price, referred to below as the “Share Acquisition Rights.” (2) Number of share acquisition rights 12,000 (5) Amount of funds raised (Approximate net proceeds) ¥3,651,836,000」
The company issued 12,000 share acquisition rights, with Daiwa Securities Co., Ltd. as the allottee. The number of potential shares was 1,200,000, and approximate net proceeds were ¥3,651,836,000. The initial exercise price was ¥3,045, the minimum exercise price was ¥2,000, and the exercise period was from 25 September 2019 to 24 September 2021.